Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Extended treatment with Intron A for hepatitis C cleared by FDA

April 1, 1997

Shaman commences phase II trials of Provir in AIDS-related diarrhea

April 1, 1997

Kaken prepares broad-spectrum antiulcer agent

March 27, 1997

Axcan receives approvable letter for URSO from FDA

March 26, 1997

Synsorb Cd enters phase II

March 26, 1997

Daiichi Pharmaceutical presents novel antisecretory agent

March 25, 1997

Byk Canada begins operations

March 21, 1997

Gastric prokinetic agent developed by Kyorin

March 19, 1997

Fujisawa prepares PLA2 inhibitors

March 19, 1997

Combination therapy for idiopathic intractable hiccup

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...